Jasper Therapeutics (JSPR) Shares Outstanding (2019 - 2025)
Jasper Therapeutics (JSPR) posted quarterly Shares Outstanding (Entity) of $19.2 million for Q4 2025, up 27.6% year-over-year from $15.0 million in Q4 2024, and up 15.22% quarter-over-quarter from $16.6 million in Q3 2025.
Jasper Therapeutics (JSPR) Shares Outstanding (2019 - 2025) Analysis & Trends
Jasper Therapeutics' Shares Outstanding (Entity) history runs 7 years deep, the most recent figure standing at $19.2 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 27.6% year-over-year to $19.2 million; the TTM figure through Dec 2025 stood at $19.2 million (up 27.6% YoY), while the FY2025 annual figure was $19.2 million, up 27.6% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $19.2 million, up from $16.6 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $19.2 million in Q4 2025, with the low at $496623.0 in Q3 2021.
- The 5-year median for Shares Outstanding (Entity) is $11.1 million (2023), against an average of $9.4 million.
- The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) tumbled 50.34% in 2021, then surged 664.85% in 2022.
- Jasper Therapeutics' Shares Outstanding (Entity) stood at $1.1 million in 2021, then soared by 233.92% to $3.8 million in 2022, then soared by 193.43% to $11.2 million in 2023, then surged by 34.56% to $15.0 million in 2024, then advanced by 27.6% to $19.2 million in 2025.
- Business Quant data shows JSPR's Shares Outstanding (Entity) at $19.2 million in Q4 2025, $16.6 million in Q3 2025, and $16.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 133.61 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 217.35 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 445.06 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 241.70 Mn |
| 10 | Jasper Therapeutics | 20.06 Mn | 20.06 Mn | - | 28.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.17 Mn |
| Sep 30, 2025 | 16.64 Mn |
| Jun 30, 2025 | 15.33 Mn |
| Mar 31, 2025 | 15.02 Mn |
| Dec 31, 2024 | 14.58 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Jun 30, 2024 | 14.99 Mn |
| Mar 31, 2024 | 13.33 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Sep 30, 2023 | 10.35 Mn |
| Jun 30, 2023 | 10.92 Mn |
| Mar 31, 2023 | 8.82 Mn |
| Dec 31, 2022 | 3.65 Mn |
| Sep 30, 2022 | 3.66 Mn |
| Jun 30, 2022 | 3.64 Mn |
| Mar 31, 2022 | 3.63 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 496,623.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |